
IMRAN IQBAL, M.D.
Dr. Iqbal has been in practice with Rheumatology Associates, Dallas, Texas since 2002.
Dr. Iqbal received his Doctor of Medicine (M.D.), from Sindh Medical College and then completed his internship and residency in Internal Medicine at Mount Sinai services at Queens Hospital Center in New York. He practiced Internal Medicine for 3 ½ years before doing a Fellowship in Rheumatology at the University of Texas Southwestern Medical Center, Dallas, Texas. He also took part in basic and clinical research while at University of Texas Southwestern Medical Center. His research was focused on inflammatory arthritis.
Dr. Iqbal is Board Certified in Internal Medicine with sub-specialty certification in Rheumatology and is a Fellow in the American College of Rheumatology and a Member of the American College of Physicians.
Dr. Iqbal is actively involved in clinical trials and has co-authored several articles.
Recent Publications:
- Safety and efficacy of disease modifying anti rheumatic agents: Focus on the Benefits and Risks of Etanercept. R Fleischmann, I Iqbal, P Nandeshwar, et al. Drug Safety 2002;25(3):173-97.
- Meloxicam. A review of safety and efficacy. R Fleischmann, I Iqbal, G Slobodin. Expert Opinions in Pharmacotherapy. 2002; 3(10):1501-12.
- Leflunomide. SB Cohen, I Iqbal. Int J Clin Pract. 2003; 57(2):115-20.
- CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. E May , ML Doris, N Satumitra, I Iqbal, et al. J Immunol. 2003 Jan 15; 170(2):1099-105.
- Anakinra: A Novel Biological Therapy for the Treatment of Rheumatoid Arthritis. R Fleischmann, R Stern, I Iqbal. Current Medical Literature-Rheumatology 2004:23(1):1-6
- Etanercept - Review of Efficacy and Safety after Five Years of Clinical Use. R Fleischmann, R Stern, I Iqbal. Therapy 2004;1(1):89-99.
- Anakinra: An Inhibitor of IL-1 for the treatment of Rheumatoid Arthritis. R Fleischmann, R Stern, I Iqbal. Expert Opinion on Biological Therapy. 2004 4(8) 1333-1341.
- Considerations with the Use of Biologic Therapy in the Treatment of Rheumatoid Arthritis. R Fleischmann, I Iqbal, R Stern. Expert Opin Drug Saf. 2004 Sep;3(5):391-403.
- Differential Diagnosis of Patient with Inflammatory Joint Pain. S Cohen, I Iqbal, R Stern. Int. Journal of Advances in Rheumatology 2004; 2(4): 120-5.
- Treatment of early rheumatoid arthritis. R M Fleischmann, R Stern, I Iqbal. Mod Rheumatology 2005.
|